We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $9.37B
1-Year Est. Return 36.4%
This Fund
S&P 500
This Quarter Est. Return
+8.78%
1 Year Est. Return
+36.4%
3 Year Est. Return
+114.29%
5 Year Est. Return
+137.63%
10 Year Est. Return
+535.77%
AUM
$3.13B
AUM Growth
+$281M
Cap. Flow
+$61.6M
Cap. Flow %
1.97%
Top 10 Hldgs %
12.2%
Holding
1,543
New
228
Increased
546
Reduced
510
Closed
166

Sector Composition

Rank Sector Weight
1 Energy 12.37%
2 Healthcare 10.59%
3 Industrials 9.5%
4 Financials 9.49%
5 Technology 9.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TROW icon
351
T. Rowe Price
TROW
$24.3B
$2.01M 0.06%
24,019
-348
-1% -$27.2K
MEOH icon
352
Methanex
MEOH
$4.12B
$2M 0.06%
33,796
+7,551
+29% +$436K
VAR
353
DELISTED
Varian Medical Systems, Inc.
VAR
$1.97M 0.06%
28,849
+593
+2% +$39.5K
CONN
354
DELISTED
Conn's Inc.
CONN
$1.96M 0.06%
24,958
+2,062
+9% +$132K
ICON
355
DELISTED
Iconix Brand Group, Inc.
ICON
$1.96M 0.06%
+4,933
New +$1.82M
BRCM
356
DELISTED
BROADCOM CORP CL-A
BRCM
$1.96M 0.06%
66,041
+1,331
+2% +$36.2K
RSE
357
DELISTED
ROUSE PPTYS INC COM (DE)
RSE
$1.96M 0.06%
88,115
MRVL icon
358
Marvell Technology
MRVL
$196B
$1.95M 0.06%
135,288
+72,565
+116% +$935K
LHX icon
359
L3Harris
LHX
$53.4B
$1.94M 0.06%
27,780
+1,859
+7% +$118K
FWONA icon
360
Liberty Media Series A
FWONA
$23.6B
$1.93M 0.06%
74,432
-62,239
-46% -$1.65M
XRX icon
361
Xerox
XRX
$425M
$1.92M 0.06%
59,771
+934
+2% +$26.9K
VUG icon
362
Vanguard Morningstar Growth ETF
VUG
$230B
$1.92M 0.06%
123,480
-12,654
-9% -$187K
XLK icon
363
State Street Technology Select Sector SPDR ETF
XLK
$123B
$1.91M 0.06%
107,106
+1,864
+2% +$31.6K
WPZ
364
DELISTED
WILLIAMS PARTNERS L.P. COM UTS REPTG L.P. INT
WPZ
$1.91M 0.06%
39,773
+4,179
+12% +$200K
MDLZ icon
365
Mondelez International
MDLZ
$79.9B
$1.9M 0.06%
53,842
-5,057
-9% -$168K
CEQP
366
DELISTED
Crestwood Equity Partners LP
CEQP
$1.9M 0.06%
13,708
-1,136
-8% -$162K
BUD icon
367
AB InBev
BUD
$165B
$1.89M 0.06%
17,784
+26
+0.1% +$2.66K
CVS icon
368
CVS Health
CVS
$122B
$1.89M 0.06%
26,422
-495
-2% -$31.8K
FXH icon
369
First Trust Health Care AlphaDEX Fund
FXH
$1.11B
$1.89M 0.06%
39,288
-688
-2% -$31.4K
RIG icon
370
Transocean
RIG
$5.82B
$1.88M 0.06%
37,975
-1,719
-4% -$84.1K
APOL
371
DELISTED
Apollo Education Group Inc Class A
APOL
$1.88M 0.06%
68,650
+25,300
+58% +$628K
NVDA icon
372
NVIDIA
NVDA
$5.42T
$1.87M 0.06%
4,678,560
-3,080,440
-40% -$1.19M
SH icon
373
ProShares Short S&P500
SH
$843M
$1.87M 0.06%
9,273
-2,932
-24% -$622K
DNR
374
DELISTED
Denbury Resources, Inc.
DNR
$1.87M 0.06%
113,866
+12,566
+12% +$222K
FVD icon
375
First Trust Value Line Dividend Fund
FVD
$8.4B
$1.87M 0.06%
87,355
+441
+0.5% +$9.2K

Similar funds

Oppenheimer & Co's Q4 2013 Portfolio in Review

As of Q4 2013, Oppenheimer & Co held 1,543 positions worth $3.13B, up 9.9% from $2.84B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Oppenheimer & Co's Q4 2013 filing shows 228 new, 546 increased, 510 reduced and 166 closed positions. Its largest new stake was TetraLogic Pharmaceuticals Corporation: 1,072,115 shares worth $10.2M. The largest sale was WisdomTree Emerging Markets Local Debt Fund, an estimated $5.52M.

By sector, the portfolio is most concentrated in Energy at 12% of assets, down from 13% a quarter earlier, followed by Healthcare and Industrials.

  • Oppenheimer & Co's largest Q4 2013 buy was TetraLogic Pharmaceuticals Corporation: 1,072,115 shares worth $10.2M.
  • Oppenheimer & Co added most to Invesco FTSE RAFI US 1000 ETF in Q4 2013, an estimated $8.14M increase.
  • Oppenheimer & Co's biggest Q4 2013 reduction was WisdomTree Emerging Markets Local Debt Fund, cutting an estimated $5.52M.
  • Oppenheimer & Co fully exited iShares Global Financials ETF in Q4 2013, selling an estimated $5.36M.
  • Oppenheimer & Co's ten largest holdings make up 12% of its $3.13B portfolio in Q4 2013.
  • Oppenheimer & Co opened 228 new positions and closed 166 in Q4 2013.
  • Oppenheimer & Co's portfolio value rose 9.9% quarter-over-quarter to $3.13B.

Based on Oppenheimer & Co's 13F filing for Q4 2013, filed 12 Feb 2014.